Survival Benefit of Neoadjuvant Treatment in Clinical T3N0M0 Esophageal Cancer
Background: Based on current guidelines, clinical T3N0M0 esophageal tumors may or may not receive neoadjuvant treatment, according to their perception as locally advanced (cT3) or early-stage tumors (stage II). The study aim was to assess the impact of neoadjuvant treatment upon survival for cT3N0M0...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , , , , , , , , , , , |
| Format: | article |
| Published: |
2017
|
| Online Access: | http://hdl.handle.net/10725/14208 https://doi.org/10.1097/SLA.0000000000002402 http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php https://pubmed.ncbi.nlm.nih.gov/28742698/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|